Pacific Edge slashes team on US 'uncertainty'

Pacific Edge slashes team on US 'uncertainty'
(Image: PEB)
Brent Melville
Pacific Edge has halved its sales team after uncertainty over its future in its core US market, with a pending decision on whether medicare contractor Novitas will cover US testing.  The cancer diagnostic company, dual listed on the New Zealand and Australian stock exchanges, slashed its commercial team from 34 to 17 as it restructured its operations after a 17.78% drop in test volumes for its Cxbladder product in its core US market for the December quarter.The Dunedin firm said it had processed 7,172 tests during the final three months of...

More Markets

No big NZ cuts amid 'Nuno-geddon': ANZ NZ
Finance

No big NZ cuts amid 'Nuno-geddon': ANZ NZ

ANZ Group chops thousands of staff, contractors, but no big cuts in NZ. 

Vista's new shareholders revealed
Markets

Vista's new shareholders revealed

Flurry of NZX notices show who's been buying Vista shares – and selling too.

Tariffs tanked markets – NZ Super Fund cashed in
Markets

Tariffs tanked markets – NZ Super Fund cashed in

The Super Fund netted $745 million from active investments. How?

Swapping mortgages for music: David Tripe eases into retirement
Finance

Swapping mortgages for music: David Tripe eases into retirement

Respected academic and finance-sector pundit calls time on his long career.